Ganciclovir

Ganciclovir

Form: Capsules

Strength: 250 mg

Reference Brands: Cytovene®(EU & US)

Category: Anti Viral

Ganciclovir Capsules 250 mg are antiviral medications used in the treatment and prevention of Cytomegalovirus (CMV) infections in immunocompromised patients, including those with HIV/AIDS or undergoing organ transplants. Though less commonly used today due to the availability of valganciclovir, Ganciclovir remains valuable in cost-sensitive markets. Available in capsule form, it is manufactured by WHO-GMP certified pharmaceutical companies and offered through PharmaB2B platforms for bulk purchasing, hospital procurement, and tender supplies. Ganciclovir Capsules offer a cost-effective solution for CMV management where oral antiviral therapy is needed and budget constraints are a concern.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Zanamivir

Strength: 5 mg/blister

Form: Inhalation powder

Reference Brands: Relenza(EU & US)

View Details Get Enquiry
Oseltamivir Phosphate Capsule

Strength: Capsule- 30 mg, 45 mg, 75 mg; Oral Suspension - 6 mg/mL (reconstituted)

Form: Capsules and Oral solution

Reference Brands: Tamiflu(EU & US)

View Details Get Enquiry
Amantadine

Strength: Tab -100 mg; Capsule- 100 mg; Oral solution - 50 mg/5 mL; Extended-release capsule (ER) - 129 mg, 193 mg

Form: Tablet; Capsule; Oral Solution and ER Capsule

Reference Brands: Symmetrel(EU & US); Osmolex ER(US), Gocovri(US)

View Details Get Enquiry
Glecaprevir + Pibrentasvir

Strength: Glecaprevir- 100 mg + Pibrentasvir - 40 mg

Form: Tablet

Reference Brands: Mavyret (US); Maviret (EU)

View Details Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.